Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8227563 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 11 Pages |
Abstract
Pancreatic cancer remains associated with an extremely poor prognosis. Surgical resection can be curative, but the majority of patients present with locally advanced or metastatic disease. Treatment for patients with locally advanced disease is controversial. Therapeutic options include systemic therapy alone, concurrent chemoradiation, or induction chemotherapy followed by chemoradiation. We review the evidence to date regarding the treatment of locally advanced pancreatic cancer (LAPC), as well as evolving strategies including the emerging role of targeted therapies. We propose that if radiation is used for patients with LAPC, it should be delivered with concurrent chemotherapy and following a period of induction chemotherapy.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Kimberly M.D., Ph.D., Muhammad Wasif M.D., M.B.B.S., Bryan W. M.D.,